Get the Stockscreener App
31.86
0.82%
0.26
After Hours:
31.86
Ideaya Biosciences Inc stock is traded at $31.86, with a volume of 1.03M.
It is up +0.82% in the last 24 hours and up +17.09% over the past month.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
See More
Previous Close:
$31.60
Open:
$31.54
24h Volume:
1.03M
Relative Volume:
0.86
Market Cap:
$2.79B
Revenue:
$23.38M
Net Income/Loss:
$-155.22M
P/E Ratio:
-14.55
EPS:
-2.19
Net Cash Flow:
$-134.36M
1W Performance:
+9.18%
1M Performance:
+17.09%
6M Performance:
+58.27%
1Y Performance:
+13.18%
1-Day Range:
$30.94
$32.14
1-Week Range:
$29.07
$33.64
52-Week Range:
$13.45
$33.64
Ideaya Biosciences Inc Stock (IDYA) Company Profile
Name
Ideaya Biosciences Inc
Sector
Industry
Phone
650-443-6209
Address
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare IDYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDYA
Ideaya Biosciences Inc
|
31.86 | 2.77B | 23.38M | -155.22M | -134.36M | -2.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Initiated | Guggenheim | Buy |
| Sep-04-25 | Initiated | Barclays | Overweight |
| Sep-04-25 | Initiated | Citizens JMP | Mkt Outperform |
| Jul-22-25 | Initiated | TD Cowen | Buy |
| Jul-10-25 | Resumed | Goldman | Neutral |
| Jun-26-25 | Initiated | Wells Fargo | Overweight |
| Nov-18-24 | Initiated | Stephens | Overweight |
| Nov-05-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-24-24 | Initiated | UBS | Buy |
| Oct-15-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-08-24 | Initiated | Mizuho | Outperform |
| Mar-08-24 | Initiated | BTIG Research | Buy |
| Aug-08-23 | Initiated | SVB Securities | Outperform |
| May-24-23 | Initiated | Goldman | Buy |
| Apr-24-23 | Upgrade | Stifel | Hold → Buy |
| Mar-23-23 | Initiated | Berenberg | Buy |
| Feb-28-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-28-22 | Initiated | CapitalOne | Overweight |
| Oct-27-22 | Initiated | Citigroup | Buy |
| Aug-15-22 | Downgrade | Stifel | Buy → Hold |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Mar-10-22 | Upgrade | Stifel | Hold → Buy |
| Sep-23-21 | Initiated | Stifel | Hold |
| Jun-04-21 | Resumed | Robert W. Baird | Outperform |
| Mar-11-21 | Initiated | Guggenheim | Buy |
| Oct-07-20 | Initiated | Wedbush | Outperform |
| Sep-01-20 | Initiated | Northland Capital | Outperform |
| Jul-13-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-17-20 | Reiterated | H.C. Wainwright | Buy |
| Apr-06-20 | Initiated | H.C. Wainwright | Buy |
| Mar-13-20 | Initiated | ROTH Capital | Buy |
| Oct-17-19 | Initiated | Oppenheimer | Outperform |
| Sep-10-19 | Initiated | Robert W. Baird | Outperform |
| Jun-17-19 | Initiated | Citigroup | Buy |
| Jun-17-19 | Initiated | JP Morgan | Neutral |
| Jun-17-19 | Initiated | Jefferies | Buy |
View All
Ideaya Biosciences Inc Stock (IDYA) Latest News
Why IDEAYA Biosciences Inc. stock appeals to analysts2025 Sector Review & Safe Entry Zone Tips - newser.com
Using AI based signals to follow IDEAYA Biosciences Inc.July 2025 Breakouts & AI Driven Stock Price Forecasts - newser.com
Is IDEAYA Biosciences Inc. stock a top momentum playFed Meeting & Reliable Price Action Trade Plans - newser.com
Will IDEAYA Biosciences Inc. (30J) stock extend growth story2025 Sector Review & Risk Adjusted Buy and Sell Alerts - newser.com
Order flow analysis tools used on IDEAYA Biosciences Inc.2025 Market Sentiment & Safe Entry Trade Reports - newser.com
IDEAYA Biosciences Inc. stock trend forecastEntry Point & Verified Short-Term Plans - newser.com
AlphaQuest LLC Sells 16,763 Shares of IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Will IDEAYA Biosciences Inc. stock remain a Wall Street favoriteMarket Volume Report & Weekly High Momentum Picks - newser.com
IDEAYA Biosciences (NASDAQ:IDYA) Upgraded at Wall Street Zen - MarketBeat
Using flow based indicators on IDEAYA Biosciences Inc.July 2025 Pullbacks & Short-Term Swing Trade Alerts - newser.com
IDEAYA Biosciences (NASDAQ: IDYA) awards 73,500 inducement options with 4-year vesting - Stock Titan
Visualizing IDEAYA Biosciences Inc. stock with heatmapsJuly 2025 Selloffs & Detailed Earnings Play Strategies - newser.com
Can IDEAYA Biosciences Inc. (30J) stock attract ESG investmentsMarket Activity Recap & Real-Time Market Trend Scan - newser.com
How to integrate IDEAYA Biosciences Inc. into portfolio analysis toolsSwing Trade & Real-Time Market Sentiment Reports - newser.com
Is IDEAYA Biosciences Inc. stock in correction or buying zoneWatch List & Verified Momentum Stock Alerts - newser.com
Clinical Trial Success Propels Ideaya Biosciences Shares to New Heights - AD HOC NEWS
Institutional scanner results for IDEAYA Biosciences Inc.Trade Analysis Summary & AI Enhanced Market Trend Forecasts - newser.com
Why IDEAYA Biosciences Inc. (30J) stock benefits from AI revolutionWeekly Stock Analysis & Low Risk Growth Stock Ideas - newser.com
Is IDEAYA Biosciences Inc. stock entering bullish territoryOil Prices & Verified Swing Trading Watchlist - newser.com
State of New Jersey Common Pension Fund D Increases Stock Holdings in IDEAYA Biosciences, Inc. $IDYA - MarketBeat
Will IDEAYA Biosciences Inc. (30J) stock beat revenue estimatesEarnings Beat & Precise Buy Zone Identification - newser.com
Published on: 2025-10-30 01:22:11 - newser.com
Published on: 2025-10-29 21:24:48 - newser.com
IDEAYA Biosciences (NASDAQ:IDYA) Sets New 52-Week HighWhat's Next? - MarketBeat
Can IDEAYA Biosciences Inc. stock sustain revenue growthMarket Activity Summary & Consistent Income Trade Recommendations - newser.com
Ideaya Biosciences Inc Stock (IDYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):